Scarica l'app Stockscreener
34.51
0.76%
-0.265
Dopo l'orario di chiusura:
34.51
0.005
+0.01%
Precedente Chiudi:
$34.77
Aprire:
$34.21
Volume 24 ore:
671.83K
Relative Volume:
0.74
Capitalizzazione di mercato:
$1.75B
Reddito:
$534.53M
Utile/perdita netta:
$-11.45M
Rapporto P/E:
-143.11
EPS:
-0.2411
Flusso di cassa netto:
$48.28M
1 W Prestazione:
+0.54%
1M Prestazione:
+19.81%
6M Prestazione:
-12.13%
1 anno Prestazione:
+18.01%
Intervallo 1D:
$33.90
$34.94
Intervallo di 1 settimana:
$33.72
$36.33
Portata 52W:
$25.36
$43.18
Atricure Inc Stock (ATRC) Company Profile
Nome
Atricure Inc
Settore
Industria
Telefono
513-755-4100
Indirizzo
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
34.51 | 1.76B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
350.06 | 125.08B | 11.03B | 3.16B | 2.83B | 8.7254 |
BDX
Becton Dickinson Co
|
153.84 | 42.57B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.09 | 32.88B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.35 | 34.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
195.80 | 28.81B | 5.54B | 1.52B | 1.74B | 10.37 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-18 | Downgrade | Oppenheimer | Outperform → Perform |
| 2026-02-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-04-23 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2021-08-05 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Reiterato | Needham | Buy |
| 2020-11-06 | Reiterato | Needham | Buy |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2020-01-24 | Reiterato | Needham | Buy |
| 2019-08-13 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Iniziato | JP Morgan | Overweight |
| 2018-10-04 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Stifel | Buy |
| 2018-06-18 | Reiterato | Needham | Buy |
| 2018-04-27 | Reiterato | Needham | Buy |
| 2018-01-16 | Reiterato | Needham | Buy |
| 2017-11-02 | Reiterato | Needham | Buy |
| 2017-07-28 | Reiterato | Needham | Buy |
| 2017-05-30 | Ripresa | Piper Jaffray | Overweight |
| 2016-06-30 | Ripresa | JMP Securities | Mkt Outperform |
| 2015-10-28 | Reiterato | Needham | Buy |
| 2015-10-06 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-06 | Reiterato | Needham | Buy |
Mostra tutto
Atricure Inc Borsa (ATRC) Ultime notizie
Citizens reiterates AtriCure stock rating on product growth outlook - Investing.com
AtriCure (ATRC) Proxy filing Summary - Quartr
(ATRC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Needham Initiates AtriCure(ATRC.US) With Buy Rating, Announces Target Price $45 - Moomoo
Needham Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $45 - Moomoo
AtriCure (ATRC) Investor Day 2025 Summary - Quartr
Is AtriCure's (ATRC) Russell 2000 Defensive Debut Quietly Reframing Its Risk‑Reward Profile? - simplywall.st
AtriCure (ATRC) Jumps Nearly 7% as Healthcare Sector Sees Renewed InterestTotal Put Call - dars.gov.et
AtriCure to announce second quarter 2026 financial results - scanx.trade
AtriCure to Announce Second Quarter 2026 Financial Results - BioSpace
Form 4 AtriCure Inc For: 2 July By Investing.com - Investing.com Canada
AtriCure (ATRC) CEO adds 636 shares through 2018 Employee Stock Purchase Plan - Stock Titan
AtriCure, Inc. (ATRC) CSO acquires 636 ESPP shares at discount - Stock Titan
AtriCure (ATRC) CLO acquires 636 shares in ESPP purchase - Stock Titan
AtriCure (ATRC) COO adds ESPP shares in routine acquisition - Stock Titan
AtriCure (ATRC) CTO adds shares through discounted Employee Stock Purchase Plan - Stock Titan
AtriCure | 4: Statement of changes in beneficial ownership of securities-Officer Privitera Salvatore - Moomoo
Press Release: AtriCure to Announce Second Quarter 2026 Financial Results - Moomoo
GRANDEUR PEAK GLOBAL MICROCAP FUND's AtriCure Inc(ATRC) Holding History - GuruFocus
Enterprise value to revenue forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Price to book forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Price to sales forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Canaccord reiterates AtriCure stock Buy rating after FDA clearance - Investing.com UK
Canaccord reiterates AtriCure stock Buy rating after FDA clearance By Investing.com - Investing.com Nigeria
CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $55 - Moomoo
AtriCure (ATRC) Q2 2025 earnings summary - Quartr
AtriCure (ATRC) Joins Multiple Russell 2000 Defensive Indexes Is Its Risk Profile Evolving? - simplywall.st
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic - MedTech Dive
AtriCure, Inc.(NasdaqGM: ATRC) added to Russell 2000 Defensive Index - marketscreener.com
AtriCure, Inc. Actuals & Estimates (NASDAQ:ATRC) - TradingView
AtriCure, Inc. Actuals & Estimates (DUS:A5I) - TradingView
ATRC Forecast — Price Target — Prediction for 2027 - TradingView
How (ATRC) Movements Inform Risk Allocation Models - Stock Traders Daily
AtriCure stock trades up with limited momentum as technical resistance remains - Traders Union
AtriCure Inc (ATRC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ATRC PE Ratio & Valuation, Is ATRC Overvalued - Intellectia AI
AtriCure stock jumps 6.19% as streamlined ablation integration takes spotlight, AtriCure reports - Traders Union
AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock? - Yahoo Finance
AtriCure Inc (ATRC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AtriCure Inc (ATRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AtriCure Inc (ATRC) Institutional Confidence - TradingKey
AtriCure Inc (ATRC) Valuation: PE, PB & Fair Value Analysis - TradingKey
AtriCure Inc (ATRC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AtriCure Inc (ATRC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AtriCure Inc (ATRC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AtriCure Inc (ATRC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AtriCure (ATRC) Holds Steady at $27.98: Consolidation Near Key Resistance LevelsHead and Shoulders - DonanımHaber
AtriCure (ATRC) Declines 2.8% as Shares Approach Critical Support at $26.58Sweep Order Flow - DonanımHaber
Trading Systems Reacting to (ATRC) Volatility - Stock Traders Daily
Do options traders know something about AtriCure stock we don't? - MSN
AtriCure (ATRC) Q1 2026 Earnings Transcript - AOL.com
Atricure Inc Azioni (ATRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.63%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):